Each month you can find the latest news and industry insights here. Including updates on the Edwards clinical studies, new evidence around TAVI procedures, features from key opinion leaders and much more. Sign up to the TAVI.today newsletter to stay informed.

Oct 2022

20 Years of TAVI – Achieving comprehensive patient management

Hear leading experts discuss how to adopt a comprehensive and patient-centred management approach in the care of severe aortic stenosis (sAS) patients

Jun 2022

Key diagnostic steps in aortic stenosis (AS) echocardiography

  • With an average survival rate of 50% at two years and 20% at five years, the timely and accurate diagnosis of AS is essential1
  • An integrated and stepwise approach to echocardiography assessment of AS is a key diagnostic tool for confirming the diagnosis and severity of AS2
  • However, it is important to understand the limitations of echocardiography to avoid the underestimation of AS severity3,5

May 2022

Challenges in treating patients with asymptomatic severe aortic stenosis (sAS)

  • Roughly 1/3 of patients with severe aortic stenosis (sAS) are asymptomatic and once symptoms develop their average survival declines1,2
  • Symptom detection is difficult with many patients attributing them to other factors3,4. Exercise testing is important for unmasking symptoms in patients with asymptomatic sAS5
  • Treatment is recommended in patients with asymptomatic severe aortic stenosis in the presence of one or more of these factors: adverse prognostic factors*, LVEF<50%, positive exercise test or symptom development6

Feb 2022

The 2021 ESC/EACTS guidelines recommend all* sAS patients with severe aortic stenosis are referred to the Heart Team1

The new 2021 ESC/EACTS VHD guidelines recommend that all* symptomatic patients with severe aortic stenosis (sAS) are referred to the Heart Team for a treatment evaluation. The Heart Team will assess multiple patient factors, including their age, their values and preferences, when making the final decision between TAVI and SAVR.1

*With treatment indication.1

Jan 2022

Important considerations for the referral of patients with severe aortic stenosis

In this recorded webinar hear from leading cardiologist Dr. Shrilla Banerjee on:

  • What sort of service does she want for her patients
  • Which patients should be referred
  • The ideal patient pathway
  • Barriers to the adoption of TAVI
  • A new tool for the referral process that includes assessment of frailty

Jul 2021

Podcast Episode 4 – Benchmarking Efficiencies, Pre, Peri and Post TAVI Procedure

In the fourth instalment of the TAVI Talk podcast series Interventional Cardiologists Dr. Sagar Doshi from The Queen Elizabeth Hospital, Birmingham and Dr. Charis Costopoulos from Royal Papworth Hospital discuss optimization of the pre, peri and post TAVI procedure.

Jul 2021

How can TAVI benefit your low-risk patients with severe aortic stenosis (sAS) now and in the future?

Supported by proven results from PARTNER 3,1 low-risk patients with sAS now have the opportunity for TAVI. As these patients are usually younger and healthier than those in higher risk categories,1-6 further considerations for this group include valve durability and valve-in-valve (ViV) procedures that support their longer-term management.

Jun 2021

Podcast Episode 3 – The Collaborative Referral

In the third instalment of the TAVI Talk podcast series, Interventional Cardiologist Dr. Karim Ratib from Royal Stoke University Hospital and Dr. Andrew Epstein, Cardiologist from Wye Valley NHS Trust discuss their Aortic Stenosis Management Service for best patient outcome.

Mar 2021

Podcast Episode 2: The Heart Team Approach

In this episode interventional cardiologists and TAVI implanters, Professor Rajesh Kharbanda, Dr Sam Dawkins, Dr Clare Appleby and Dr Joe Mills discuss:

  • The Heart Team approach to patients with Aortic Stenosis
  • the impact of referrals at times of limited resources
  • how a streamlined, efficient TAVI referral pathway can minimise healthcare footprint.

Feb 2021

Podcast Episode 1: TAVI evolution and patient choice

In this episode, interventional cardiologists and TAVI implanters, Professor Rajesh Kharbanda, Dr Sam Dawkins, Dr Clare Appleby and Dr Joe Mills discuss how far the TAVI procedure has come over the last decade, the evidence base supporting this and what patient choice means to them.

Aug 2020

TAVI under conscious sedation – enabling continuity of treatment for your sAS patients

It remains essential that your severe aortic stenosis (sAS) patients continue to be referred for treatment, however many of them may be anxious about spending time in hospital and need a treatment that offers a shorter hospital stay and quicker return home. TAVI under conscious sedation can offer a range of benefits and address these patient needs.

Stay informed with our newsletter

By providing your personal information, you agree to allow Edwards Lifesciences and its agents to use this information to communicate with you in the future, including information about services, events, and programs. Edwards Lifesciences and its agents will not sell, rent, or otherwise distribute your name and any personally identifiable information outside of Edwards Lifesciences and its agents, Edwards Lifesciences will use your information in accordance with the Edwards privacy policy.

Our monthly updates provide you the latest developments in TAVI and aortic stenosis.Read more

Medical device for professional use. For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult eifu.edwards.com where applicable).

PP--EU-1694 v2.0